MiR-146a reduces fibrosis after glaucoma filtration surgery in rats
Open Access
- 8 May 2024
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 22 (1) , 1-13
Abstract
Purpose: To explore the impact of microRNA 146a (miR-146a) and the underlying mechanisms in profibrotic changes following glaucoma filtering surgery (GFS) in rats and stimulation by transforming growth factor (TGF)-β1 in rat Tenon’s capsule fibroblasts. Methods: Cultured rat Tenon’s capsule fibroblasts were treated with TGF-β1 and analyzed with microarrays for mRNA profiling to validate miR-146a as the target. The Tenon’s capsule fibroblasts were then respectively treated with lentivirus-mediated transfection of miR-146a mimic or inhibitor following TGF-β1 stimulation in vitro, while GFS was performed in rat eyes with respective intraoperative administration of miR-146a, mitomycin C (MMC), or 5-fluorouracil (5-FU) in vivo. Profibrotic genes expression levels (fibronectin, collagen Iα, NF-KB, IL-1β, TNF-α, SMAD4, and α-smooth muscle actin) were determined through qPCR, Western blotting, immunofluorescence staining and/or histochemical analysis in vitro and in vivo. SMAD4 targeting siRNA was further used to treat the fibroblasts in combination with miR-146a intervention to confirm its role in underlying mechanisms. Results: Upregulation of miR-146a reduced the proliferation rate and profibrotic changes of rat Tenon’s capsule fibroblasts induced by TGF-β1 in vitro, and mitigated subconjunctival fibrosis to extend filtering blebs survival after GFS in vivo, where miR-146a decreased expression levels of NF-KB-SMAD4-related genes, such as fibronectin, collagen Iα, NF-KB, IL-1β, TNF-α, SMAD4, and α-smooth muscle actin(α-SMA). Additionally, SMAD4 is a key target gene in the process of miR-146a inhibiting fibrosis. Conclusions: MiR-146a effectively reduced TGF-β1-induced fibrosis in rat Tenon’s capsule fibroblasts in vitro and in vivo, potentially through the NF-KB-SMAD4 signaling pathway. MiR-146a shows promise as a novel therapeutic target for preventing fibrosis and improving the success rate of GFS.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (82070953)
This publication has 32 references indexed in Scilit:
- A New Model of Glaucoma Filtering Surgery in the RatJournal of Glaucoma, 2004
- MicroRNAs: small RNAs with a big role in gene regulationNature Reviews Genetics, 2004
- MicroRNAsCell, 2004
- Mediation of Transforming Growth Factor-β1-Stimulated Matrix Contraction by FibroblastsThe American Journal of Pathology, 2003
- Local effects of previous conjunctival incisional surgery and the subsequent outcome of filtration surgeryAmerican Journal of Ophthalmology, 1998
- Neutralisation of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarringJournal of Cell Science, 1995
- Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblastsJournal of Cell Biology, 1993
- Serious Complications of Topical Mitomycin-C after Pterygium SurgeryOphthalmology, 1992
- Serious Corneal Complications of Glaucoma Filtering Surgery With Postoperative 5-FluorouracilAmerican Journal of Ophthalmology, 1987
- 5-Fluorouracil toxicity to the ocular surface epithelium.1985